ClinicalTrials.gov
public full text
Public Domain
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
colorectal-canceregfrmetastatic-colorectal-cancernon-small-cell-lung-cancertriple-negative-breast-cancer
The purpose of this study was to evaluate the safety and tolerability of escalating doses of the MM-121 plus cetuximab and the MM-121 plus cetuximab plus irinotecan combination.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors#1349652
- Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL#1100662
- Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001)#1364348
- Study of LTC004 in Subjects With Advanced Malignant Tumors#802544
- Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies#907303
Record · ID 1419190
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive